AdaptHealth (AHCO) vs QuidelOrtho (QDEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
AdaptHealth (AHCO) has outperformed QuidelOrtho (QDEL) over the past year, losing 32.3% versus a loss of 55.5%. Over five years, AHCO leads with a -76.0% price change compared with -90.3% for QDEL. QuidelOrtho is the larger company by market cap ($877.8 million vs $796.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AHCO | QDEL |
|---|---|---|
| Share price | $5.97 | $12.80 |
| Market cap | $796.45M | $877.77M |
| 1-day change | -1.57% | +3.14% |
| YTD return | -39.11% | -56.55% |
| 1-year return | -32.31% | -55.46% |
| 5-year return | -75.99% | -90.32% |
| Forward P/E | — | 8.88 |
| EPS (TTM) | $-1.82 | $-15.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.43 | $35.58 |
| 52-week low | $5.21 | $9.92 |
| Distance from 52-week high | -55.55% | -64.02% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +48.41% | +14.61% |
| Average volume | 2.91M | 1.51M |
| Shares outstanding | 133.41M | 68.58M |
| Employees | 10,900 | 6,500 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AHCO has outperformed QDEL by 23.1 percentage points over the past year.
About AdaptHealth
AHCO stock →AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments.
Health Care · Medical/Nursing Services · 10,900 employees
About QuidelOrtho
QDEL stock →QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 6,500 employees
AHCO vs QDEL FAQ
Which is bigger, AdaptHealth or QuidelOrtho?
QuidelOrtho (QDEL) is larger, with a market capitalization of $877.77M compared with $796.45M for AdaptHealth (AHCO).
Which stock has performed better over the past year, AHCO or QDEL?
AHCO returned -32.31% over the past 12 months, compared with -55.46% for QDEL (price return, excluding dividends). Past performance does not predict future results.
Are AdaptHealth and QuidelOrtho in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Nursing Services for AdaptHealth and Biotechnology: In Vitro & In Vivo Diagnostic Substances for QuidelOrtho.